Exchange: NASDAQ·Updated 01:17 PM EST
HELP logo

HELP Helus Pharma Inc.

$9.42
$0.455
(5.08%)
Today
EarningsNov 12
Mkt Cap$654.62M
Vol694,253.00

About HELP

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.
58

Bullish Sentiment

How do you feel about HELP?

VikaDelic
$HELP predictable pre-catalyst FUD. if you are newer to biotech catalyst trading, mark the ‘feeling’ you have today… and buy the biotechs you like whenever you recognize this same feeling… it’s purposely designed to get you to sell, and it usually occurs predictably in most worthwhile tickers and typically close to data. If you aren’t overly frustrated or fearful at some point, it’s probably not a stock that will pay you well, or it’s still too early in the timeline. Stages of accumulation designed to get various retail personalities to predictably sell- 1) pay you more and more, then 2) flush momentum traders from 1 by boring you to death with a pattern that seems unbreakable, then 3) scare you as much as possible on low volume days when accumulation is almost over and their positions are locked. Buffet said it best, be greedy when others are overly fearful. Not much time left to wait brothers
2
19
rickshorses
$HELP Compass Pathways has a Price/Book over 8, ours is slightly over 3. We have room to run IF Phase 3 is Very Good. Do your own research. All is my opinion.
15
putINwork
$HELP $CMPS - Psilocybin is not some magic trip. It is now a scientifically backed molecule that enhances neuron connectivity which is lost in depression. Neuronal regrowth is a key to treating depression and is a completely different mechanism compared to traditional therapies like SSRIs and SNRIs. AND IT WORKS!!!
22
rickshorses
$HELP In biotech, it is highly COMMON for "founding" executives to hand over day-to-day operations to seasoned commercial or clinical trial managers right before a drug hits the market. Because they retained their seats on the Board of Directors, this signals a structured corporate evolution rather than a lack of confidence or an emergency exit. Do your own due diligence. IMO.
1
16
Securethetendies
$HELP $CMPS started healthy positions here today . Excited. Sold mindmed too soon and I won’t make the same mistake #mentalhealth $LCID $AAPL
18
RuddyRolls
$HELP one of these day you will wake up and this will be 30 or 40 bucks a throw. All the signs are there. Turn on, tune in, drop an HLP003.
17
putINwork
$HELP goodluck to everyone selling after holding for this long, this is the lowest you’ll see prices. It is the midterms and at the end of the week it will be too late to buy back in at these prices!!
16
putINwork
$HELP midterms are over, this is the compound which will have the shortest clinic times in the sector and be covered by insurance as THE ONLY on-label FDA approved adjunctive therapy for depression treatment (patients do not have to stop what they are on to take it.) This eliminates a terrifying prospect for severely depressed patients and allows them to not have to stop what they are on to use this and get further relief. Macro headwinds should settle this week and Phase 3 results just weeks away. All of this is Bullish!!
1
12
RuddyRolls
$HELP but yeah if you are on the fence this was a steal at $12-$14 - which is why the insiders loaded in 100k blocks at that price. Sure it's a binary but I think it's an 80/20 one. 80 per cent you win 20 per cent you lose. A stunning deal then that will not last. Slap that bloody arsk now if you are sure you want in it might be the final day today. Likely you'll have early next week too. Beyond that very risky to wait.
2
7
rickshorses
$HELP I hope Compass COMP360 gets approved it'll left the entire psychedelic sector, and we'll be next. It'll help us get approved easier since ours is just a modified variant. We get the data any day now they said in Q4 they would release the Phase 3 results and there are only two months left. And, I think it happens within the next 8 trading days. They must have at least preliminary results and know how well HLP003 works. Fingers crossed. IMO.
1
12
SolNur
$HELP Currently, DFTX holds the “best in class” Phase 3 readout. If HELP can slightly beat their MDD numbers in a shorter time span for treatment, the market cap difference will be huge.
1
12
RkyMtnChi
$HELP trial studies complete as of 10/23. I would expect them to announce results within the next few weeks.
15
Astrowen
$HELP just snagged 500 more shares .85, personally I hope an acquisition isn’t imminent just yet but whatever happens, happens. If it is a buyout, hopefully it’s a better deal than ATAI.
15
Compassbuyer
$HELP price target end of the year: 54$ . Let's go, baby!! To the Moon. There are going to be many buyers in future... good news coming soon. Bang bang. Extremely bullish.
14
CuriousChimps
$HELP I had a substantial holding in DFTX for 6 years, added every dip. And it paid off massively. This is the same situation.
14
Sailingsoon
$HELP congratulations USA There is hope on the horizon Let’s hope that the dark times come to an end
1
10
Mokksen
$HELP this is a short lived scare. The market needs a bit of time to differentiate rumour from facts and to understand the difference between natural psilocybin and a superior next generation molecule like hlp003. Phase 3 topline data is much more important for us. Don’t panic on the titanic (as the germans like to put it). 🐸❤️
13
outlawinvestor1
$HELP i have a lot of conviction in hlp003; however, if you're over 2x in gains be smart, stash some gains and play with house money into the ph3 readout. based on last patient in (late july) + 12-week protocol/cro processing, i predict topline will likely be released between next week - nov 24.
1
10
BoiBiotech
$HELP Does people really think that a person like Halstead,who always lead big companies,could have accepted a leading role here if HLP003 didn't work? C'mon,be realistic.
1
8
kev90123
$HELP Does this mean Phase 3 results will be released before then? Clock's ticking. Each day you don't the stock price drops further meaning significantly more dilution for existing shareholders when you do your raise with the release of results, regardless of how good the results are.
3
3

Advertisement|Remove ads.